Primary pulmonary synovial sarcoma.

ABSTRACT:

Objective

Primary pulmonary synovial sarcoma (PPSS) is extremely rare. This study aims to identify the clinicopathologic and therapeutic factors determining survival in PPSS.

Methods

We performed a retrospective analysis of 121 patients from the Surveillance, Epidemiology, and End Results Database as well as 12 patients from our own institution diagnosed with PPSS. Patient survival was evaluated using the Kaplan-Meier method.

Results

The median survival time for 12 PPSS patients in our institution was 78 months. Postoperative chemotherapy (P = .027 for overall survival and P = .035 for disease-specific survival) was associated with superior survival, whereas pneumonectomy (P = .011 for overall survival and P = .006 for disease-specific surv

SUBMITTER: Wang W 

PROVIDER: S-EPMC9390693 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature